Brazil Pharmaceuticals & Healthcare Report Q4 2013 - New Market Research Report
Although Sanofi's 'disappointing quarter' as well as currency devaluation in Brazil created certain market unease, the sales performance of multinationals has remained positive. The increasing demand for advanced medicines in the country continues to drive innovative drugmakers' revenue growth. However, key factors to multinationals' success, such as intimate relationship with Brazilian authorities and deeper integration with local drugmakers, may become their undoing in long-term. Multinationals will face more fierce generic competition and increasing intervention from local authorities.
View full press release